L 6 mangment
•Download as PPTX, PDF•
0 likes•72 views
لمخاطر البيولوجية، والمعروفة أيضا باسم بيوهازاردز، تشير إلى المواد البيولوجية التي تشكل خطرا على صحة الكائنات الحية، وبصفة أساسية من البشر. وهذا يمكن أن يشمل النفايات الطبية أو عينات من الكائنات الحية الدقيقة، والفيروسات أو السموم (من مصدر بيولوجي) التي يمكن أن تؤثر على صحة الإنسان. ويمكن أن تشمل أيضا المواد الضارة بالحيوانات الأخرى.
Report
Share
Report
Share
Recommended
Application of Biorisk Management For Training and Research on Animals
Seminar Presentation on Biosafety and Biosecurity Considerations and Implications When Working with Animals on the Field or in the Laboratory
lecture 9.Introduction to Biosecurity
Biosecurity refers to protecting microbial agents from loss, theft, diversion or misuse. The objective is to prevent loss, theft or misuse of microorganisms, biological materials, and research information by limiting access to facilities, materials and information. Biosafety and biosecurity measures are usually complementary, though sometimes conflicting. Biosafety focuses on appropriate laboratory procedures and practices to prevent exposures and infections, while biosecurity addresses procedures to ensure biological materials and information remain secure. Valuable biological materials require specific protective and monitoring measures to protect populations from potential harm and economic or historical value. Key principles of biosecurity include restricting information and communication, coding samples in storage, and having barriers in case of emergencies. Components of lab
Safety considerations and guidelines veterinary microbiology laboratory
This document provides guidelines on biosafety and biosecurity for veterinary microbiology laboratories. It defines key terms like biohazard, biosafety, risk assessment, biosecurity, and the biohazard symbol. It discusses the chain of infection and approaches to reduce risk of exposure like risk assessment, personal protective equipment, immunizations, and surveillance. The document also compares and contrasts biosecurity and biosafety. It provides guidance on developing a biosecurity program and addressing breaches. It discusses challenges of preventing interference while ensuring legitimate access.
Biosafety & biosecurity lab biosecurity
The Laboratory biosafety emphasizes the use of good microbiological practices, appropriate containment equipment, proper facility design, operation/maintenance and administrative considerations to minimize the risk of worker injury or illness.
What is public health
Public health aims to improve health through healthy lifestyles, disease prevention, and controlling infectious illnesses. Biosecurity encompasses actions, systems, and policies that protect people from harmful biological agents using risk reduction methods like personal protective equipment, laboratory containment systems, and decontamination techniques. Containment has two types - primary protects personnel through good practices and safety equipment, while secondary protects the external environment through facility design and operational practices.
Presentation1.pptx
This document discusses laboratory biosafety and biosecurity. It defines biosafety as containment practices that prevent exposure to biological agents, while biosecurity aims to prevent unauthorized access. The introduction notes that most laboratory infections are due to human factors rather than engineering issues. It then covers risk assessment, identifying hazards alone do not pose risk and facilities must assess risk and implement controls. Later sections discuss core biosafety requirements, heightened controls, maximum containment, transportation, and management of biosafety programs and laboratory biosecurity.
Laboratory Biosecurity by Dr.Abdoalati Mohammed Alswehli
This document discusses laboratory biosecurity and defines it as protecting, controlling, and accounting for valuable biologic material to prevent unauthorized access, loss, theft, misuse, diversion, or intentional release. It notes that increased security is needed to safeguard public health from potential bioterrorism. Valuable biologic material includes pathogens, toxins, vaccines, genetically modified organisms, and cellular components. Biosecurity is important to prevent dual-use research of concern from being used for biowarfare or terrorism. The principles of biosecurity include restricted information and communication, coding of samples, barriers in emergencies, and addressing gaps between senders and receivers. Components of lab biosecurity include physical security, personnel security, material
Biosafety and biosecurity biosafety levels
This document discusses biosafety and biosecurity. It defines biosafety as containment principles and practices to prevent unintentional exposure to pathogens. This includes laboratory worker protection, containment design, guidelines and safe practices. It describes World Health Organization (WHO) risk groups 1-4 which categorize agents based on factors like pathogenicity. It also outlines biosafety levels 1-4 which are determined by composite factors including containment and procedures. The document emphasizes principles like risk assessment, training, and emergency response planning. It defines biosecurity as measures to prevent theft or intentional release of pathogens. Developing strong biosafety and biosecurity programs requires involvement from various stakeholders.
Recommended
Application of Biorisk Management For Training and Research on Animals
Seminar Presentation on Biosafety and Biosecurity Considerations and Implications When Working with Animals on the Field or in the Laboratory
lecture 9.Introduction to Biosecurity
Biosecurity refers to protecting microbial agents from loss, theft, diversion or misuse. The objective is to prevent loss, theft or misuse of microorganisms, biological materials, and research information by limiting access to facilities, materials and information. Biosafety and biosecurity measures are usually complementary, though sometimes conflicting. Biosafety focuses on appropriate laboratory procedures and practices to prevent exposures and infections, while biosecurity addresses procedures to ensure biological materials and information remain secure. Valuable biological materials require specific protective and monitoring measures to protect populations from potential harm and economic or historical value. Key principles of biosecurity include restricting information and communication, coding samples in storage, and having barriers in case of emergencies. Components of lab
Safety considerations and guidelines veterinary microbiology laboratory
This document provides guidelines on biosafety and biosecurity for veterinary microbiology laboratories. It defines key terms like biohazard, biosafety, risk assessment, biosecurity, and the biohazard symbol. It discusses the chain of infection and approaches to reduce risk of exposure like risk assessment, personal protective equipment, immunizations, and surveillance. The document also compares and contrasts biosecurity and biosafety. It provides guidance on developing a biosecurity program and addressing breaches. It discusses challenges of preventing interference while ensuring legitimate access.
Biosafety & biosecurity lab biosecurity
The Laboratory biosafety emphasizes the use of good microbiological practices, appropriate containment equipment, proper facility design, operation/maintenance and administrative considerations to minimize the risk of worker injury or illness.
What is public health
Public health aims to improve health through healthy lifestyles, disease prevention, and controlling infectious illnesses. Biosecurity encompasses actions, systems, and policies that protect people from harmful biological agents using risk reduction methods like personal protective equipment, laboratory containment systems, and decontamination techniques. Containment has two types - primary protects personnel through good practices and safety equipment, while secondary protects the external environment through facility design and operational practices.
Presentation1.pptx
This document discusses laboratory biosafety and biosecurity. It defines biosafety as containment practices that prevent exposure to biological agents, while biosecurity aims to prevent unauthorized access. The introduction notes that most laboratory infections are due to human factors rather than engineering issues. It then covers risk assessment, identifying hazards alone do not pose risk and facilities must assess risk and implement controls. Later sections discuss core biosafety requirements, heightened controls, maximum containment, transportation, and management of biosafety programs and laboratory biosecurity.
Laboratory Biosecurity by Dr.Abdoalati Mohammed Alswehli
This document discusses laboratory biosecurity and defines it as protecting, controlling, and accounting for valuable biologic material to prevent unauthorized access, loss, theft, misuse, diversion, or intentional release. It notes that increased security is needed to safeguard public health from potential bioterrorism. Valuable biologic material includes pathogens, toxins, vaccines, genetically modified organisms, and cellular components. Biosecurity is important to prevent dual-use research of concern from being used for biowarfare or terrorism. The principles of biosecurity include restricted information and communication, coding of samples, barriers in emergencies, and addressing gaps between senders and receivers. Components of lab biosecurity include physical security, personnel security, material
Biosafety and biosecurity biosafety levels
This document discusses biosafety and biosecurity. It defines biosafety as containment principles and practices to prevent unintentional exposure to pathogens. This includes laboratory worker protection, containment design, guidelines and safe practices. It describes World Health Organization (WHO) risk groups 1-4 which categorize agents based on factors like pathogenicity. It also outlines biosafety levels 1-4 which are determined by composite factors including containment and procedures. The document emphasizes principles like risk assessment, training, and emergency response planning. It defines biosecurity as measures to prevent theft or intentional release of pathogens. Developing strong biosafety and biosecurity programs requires involvement from various stakeholders.
10 safety guidelines for recombinant dna research
This document discusses biosafety guidelines for recombinant DNA research. It defines biosafety as applying safety principles to potentially hazardous biological materials or organisms. Guidelines have been developed by organizations like the National Institutes of Health and Department of Biotechnology in India. There are four biosafety levels depending on the risk posed by the organisms and experiments, with increasing safety requirements at higher levels. Risk assessment involves evaluating characteristics of the organisms and modifications to determine the biosafety level needed. Risk management aims to minimize risks to human health and the environment through prevention measures and policies.
Biosafety lecture 1[1]
This document discusses biosafety principles for microbiology and biomedical laboratories. It defines biosafety and outlines key concepts like biohazards, biosafety levels, and the biohazard symbol. Biosafety aims to minimize health and environmental risks from hazardous biological materials through administrative controls, safety equipment, and facility design tailored to the risks involved. The document also notes emerging issues at the intersection of biosafety and biotechnology like genetically modified organisms, biosecurity, and bioethics.
Regulations for safety in biological plants
This document outlines regulations for safety in biological plants regarding biohazards and biosecurity. It defines key terms like biohazard, biosecurity, and biosafety. It discusses safety basics in biological plants including biosafety in the lab and personal biosafety. It covers national regulations in India for biological safety as well as international regulations. Guidelines are provided for risk assessment, pathogen assessment, biosafety levels, good manufacturing practices, and the roles of various containment barriers.
biosafety1.pdf
https://www.udemy.com/course/virology-4-you/?referralCode=560D93567534F41DC350
https://www.youtube.com/channel/UC_3wtJajHX0nNMqYpl2UFDA/videos
biosafety1.pdf
Biosafety levels (BSL) identify protective measures needed in laboratories to protect workers, the environment, and public. BSL are defined in Biosafety in Biomedical Laboratories and outline specific practices, safety requirements, and facility requirements. There are many ways to combine equipment, practices, and design to achieve appropriate biosafety and biocontainment determined through risk assessments of experimental protocols. Personal protective equipment (PPE) appropriate for the hazardous agent and laboratory procedure is also determined through risk assessment. Biosafety cabinets are one type of biocontainment equipment that provide personnel, environmental, and product protection through HEPA filters and different designs are used depending on the level of protection needed.
Safety and biosecurity (lab1)
This document discusses biosafety and biosecurity in laboratories. It defines laboratory biosafety as containment practices to prevent exposure to pathogens, and biosecurity as protecting valuable biological materials. It also defines bioterrorism, biohazards, risk, and biomedical waste. The document outlines objectives of biological safety including protecting workers, maintaining a safe work environment, and preventing spread of contaminants. It lists 12 rules of biosafety such as proper training, handling all biological material as potentially infectious, using appropriate biosafety levels, and reporting any accidents.
Biosecurity and Disease Security
Biosecurity and Disease security (or Biosafety) are key elements when working in laboratory. This presentation focuses on the basics of the above mentioned topics for educational as well as practical purposes.
Bio-Safety Guidelines
The document provides a detailed overview on the basic principles of operating a biotech or micro laboratory along with basic techniques with which to handle organisms, chemicals &equipment and ensuring your own, your colleagues and your environment's safety.
BIOSAFETY.pptx
The document discusses biosafety, which aims to reduce risks from infectious agents and genetically modified organisms. Biosafety involves containment conditions and preventing exposure of laboratory workers, the public, and environment. It defines four biosafety levels based on risk groups of biological agents, with higher levels requiring more stringent containment and personal protective equipment. Risk assessment involves identifying and analyzing hazards to determine potential adverse effects of biotechnology research.
Biosafety Risk Assessments
This document provides information on performing risk assessments for various types of biosafety work. It discusses risk assessments for microbiological work, animal biosafety, genetically modified plants, and genetically modified organisms. For each type of risk assessment, it identifies key factors to consider such as pathogenicity, routes of infection, survival in the environment, and availability of treatments. It emphasizes that risk assessments should be performed by those most familiar with the specific organisms, equipment, and facilities being used.
Amee write-up on - POTENTIAL HAZARDS ASSOCIATED WITH WORK PRACTICES
This document summarizes a workshop paper on potential biohazards in a pathological department associated with daily work practices. It discusses hazards from work practices, safety equipment, and facility safeguards. Potential hazards include exposure to microbial aerosols and droplets from improperly functioning biosafety cabinets, sealed rotors, or ventilation systems. Training and maintenance of safety equipment is important to ensure proper operation and containment. Facility safeguards like directional airflow also help prevent accidental release of agents and their transmission to other areas. A risk assessment approach is outlined to identify agent and procedure hazards, determine the appropriate biosafety level, and select additional precautions to reduce risks to workers.
Amee write-up on - POTENTIAL HAZARDS ASSOCIATED WITH WORK PRACTICES
This document summarizes the potential bio-hazards associated with daily work practices in a pathological department. It discusses hazards from work practices, safety equipment, and facility safeguards. Proper training and safety protocols are important to reduce risks of exposure to hazardous agents. A risk assessment should evaluate hazards from agents, laboratory procedures, equipment functionality, and staff proficiency. Reviews with safety experts can help ensure appropriate safety levels.
Biorisk Management 2020.pptx
this lecture give general overview on BIORISK management
as :
Contaminant principles and practices that are implemented to prevent the unintentional exposure to pathogens and toxins, or their accidental release defined as Biosafety
principles, technologies and practices and strategies aimed at minimizing the intentional misuse and release of a biological agent defined as Biosecurity
Preventing the next pandemic
This document defines key terms related to biosafety and biosecurity risk assessment. It discusses the importance of risk assessment for effective resource allocation and regulatory compliance. Risk assessments should be performed initially and periodically, or when changes occur. They involve identifying hazards and risks, characterizing risks based on likelihood and consequences, determining if risks are acceptable, and implementing mitigation measures if needed. The processes for biosafety and biosecurity risk assessments are outlined, including defining the scenario or situation, risks, characterizing risks, acceptability determination, and risk mitigation implementation.
Presentation Reinoud Bouwer
Presentation held during the workshop 'Biosecurity at the Science-Policy Nexus: Developing a Vision for the Future'
BIOSAFETY MANAGEMENT.ppt
This document discusses biosafety and biocontainment levels. It describes the risks associated with biological research, including hazards from pathogens and laboratory procedures. Pathogens are classified into four risk groups based on infectivity and severity of disease. Containment levels including biological and physical containment help reduce exposure risks. Primary containment involves laboratory practices and equipment while secondary containment involves facility design. Facilities are designated as biosafety level I, II or III depending on the risk group of pathogens handled.
Biosafety
The document discusses biosafety principles and practices for protecting laboratory personnel and the environment from exposure to potentially infectious biological materials and agents, including determining the risks posed by different agents, assessing those risks, and establishing biosafety levels and containment procedures appropriate to the level of risk.
Introduction to biosafety
The document provides an introduction to biosafety, explaining that it aims to reduce risk of exposure to infectious materials through proper safety precautions and procedures. It discusses the need for biosafety in laboratories processing infectious agents and around recombinant DNA to protect workers and the environment. The document also outlines different biosafety levels and associated practices, containment facilities, risk groups of pathogens, and considerations for risk assessments.
patient safety.pptx
This document discusses various hazards faced by healthcare workers and methods to control risks. It addresses bloodborne pathogens, chemical exposures, musculoskeletal disorders, and infectious diseases. For each hazard, it lists elimination, substitution, engineering controls, administrative controls, and personal protective equipment as approaches to risk control. Examples are provided such as proper sharps disposal, infection control training, patient lifting devices, negative pressure isolation rooms, and PPE like gloves and gowns. The overall purpose is to outline major occupational health and safety issues in healthcare and approaches to mitigate risks.
Biosafety
According to the Centre Of Disease Control and Prevention (CDC), Biosafety is the application of safety precautions that reduce a laboratorian’s risk of exposure to a potentially infectious material and limit contamination of the work environment and ultimately the community.
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfChulalongkorn Allergy and Clinical Immunology Research Group
Pollen and Fungal allergy
Presented by Chaloemchai Chumsaengchotsakul, MD.
June 14, 2024More Related Content
Similar to L 6 mangment
10 safety guidelines for recombinant dna research
This document discusses biosafety guidelines for recombinant DNA research. It defines biosafety as applying safety principles to potentially hazardous biological materials or organisms. Guidelines have been developed by organizations like the National Institutes of Health and Department of Biotechnology in India. There are four biosafety levels depending on the risk posed by the organisms and experiments, with increasing safety requirements at higher levels. Risk assessment involves evaluating characteristics of the organisms and modifications to determine the biosafety level needed. Risk management aims to minimize risks to human health and the environment through prevention measures and policies.
Biosafety lecture 1[1]
This document discusses biosafety principles for microbiology and biomedical laboratories. It defines biosafety and outlines key concepts like biohazards, biosafety levels, and the biohazard symbol. Biosafety aims to minimize health and environmental risks from hazardous biological materials through administrative controls, safety equipment, and facility design tailored to the risks involved. The document also notes emerging issues at the intersection of biosafety and biotechnology like genetically modified organisms, biosecurity, and bioethics.
Regulations for safety in biological plants
This document outlines regulations for safety in biological plants regarding biohazards and biosecurity. It defines key terms like biohazard, biosecurity, and biosafety. It discusses safety basics in biological plants including biosafety in the lab and personal biosafety. It covers national regulations in India for biological safety as well as international regulations. Guidelines are provided for risk assessment, pathogen assessment, biosafety levels, good manufacturing practices, and the roles of various containment barriers.
biosafety1.pdf
https://www.udemy.com/course/virology-4-you/?referralCode=560D93567534F41DC350
https://www.youtube.com/channel/UC_3wtJajHX0nNMqYpl2UFDA/videos
biosafety1.pdf
Biosafety levels (BSL) identify protective measures needed in laboratories to protect workers, the environment, and public. BSL are defined in Biosafety in Biomedical Laboratories and outline specific practices, safety requirements, and facility requirements. There are many ways to combine equipment, practices, and design to achieve appropriate biosafety and biocontainment determined through risk assessments of experimental protocols. Personal protective equipment (PPE) appropriate for the hazardous agent and laboratory procedure is also determined through risk assessment. Biosafety cabinets are one type of biocontainment equipment that provide personnel, environmental, and product protection through HEPA filters and different designs are used depending on the level of protection needed.
Safety and biosecurity (lab1)
This document discusses biosafety and biosecurity in laboratories. It defines laboratory biosafety as containment practices to prevent exposure to pathogens, and biosecurity as protecting valuable biological materials. It also defines bioterrorism, biohazards, risk, and biomedical waste. The document outlines objectives of biological safety including protecting workers, maintaining a safe work environment, and preventing spread of contaminants. It lists 12 rules of biosafety such as proper training, handling all biological material as potentially infectious, using appropriate biosafety levels, and reporting any accidents.
Biosecurity and Disease Security
Biosecurity and Disease security (or Biosafety) are key elements when working in laboratory. This presentation focuses on the basics of the above mentioned topics for educational as well as practical purposes.
Bio-Safety Guidelines
The document provides a detailed overview on the basic principles of operating a biotech or micro laboratory along with basic techniques with which to handle organisms, chemicals &equipment and ensuring your own, your colleagues and your environment's safety.
BIOSAFETY.pptx
The document discusses biosafety, which aims to reduce risks from infectious agents and genetically modified organisms. Biosafety involves containment conditions and preventing exposure of laboratory workers, the public, and environment. It defines four biosafety levels based on risk groups of biological agents, with higher levels requiring more stringent containment and personal protective equipment. Risk assessment involves identifying and analyzing hazards to determine potential adverse effects of biotechnology research.
Biosafety Risk Assessments
This document provides information on performing risk assessments for various types of biosafety work. It discusses risk assessments for microbiological work, animal biosafety, genetically modified plants, and genetically modified organisms. For each type of risk assessment, it identifies key factors to consider such as pathogenicity, routes of infection, survival in the environment, and availability of treatments. It emphasizes that risk assessments should be performed by those most familiar with the specific organisms, equipment, and facilities being used.
Amee write-up on - POTENTIAL HAZARDS ASSOCIATED WITH WORK PRACTICES
This document summarizes a workshop paper on potential biohazards in a pathological department associated with daily work practices. It discusses hazards from work practices, safety equipment, and facility safeguards. Potential hazards include exposure to microbial aerosols and droplets from improperly functioning biosafety cabinets, sealed rotors, or ventilation systems. Training and maintenance of safety equipment is important to ensure proper operation and containment. Facility safeguards like directional airflow also help prevent accidental release of agents and their transmission to other areas. A risk assessment approach is outlined to identify agent and procedure hazards, determine the appropriate biosafety level, and select additional precautions to reduce risks to workers.
Amee write-up on - POTENTIAL HAZARDS ASSOCIATED WITH WORK PRACTICES
This document summarizes the potential bio-hazards associated with daily work practices in a pathological department. It discusses hazards from work practices, safety equipment, and facility safeguards. Proper training and safety protocols are important to reduce risks of exposure to hazardous agents. A risk assessment should evaluate hazards from agents, laboratory procedures, equipment functionality, and staff proficiency. Reviews with safety experts can help ensure appropriate safety levels.
Biorisk Management 2020.pptx
this lecture give general overview on BIORISK management
as :
Contaminant principles and practices that are implemented to prevent the unintentional exposure to pathogens and toxins, or their accidental release defined as Biosafety
principles, technologies and practices and strategies aimed at minimizing the intentional misuse and release of a biological agent defined as Biosecurity
Preventing the next pandemic
This document defines key terms related to biosafety and biosecurity risk assessment. It discusses the importance of risk assessment for effective resource allocation and regulatory compliance. Risk assessments should be performed initially and periodically, or when changes occur. They involve identifying hazards and risks, characterizing risks based on likelihood and consequences, determining if risks are acceptable, and implementing mitigation measures if needed. The processes for biosafety and biosecurity risk assessments are outlined, including defining the scenario or situation, risks, characterizing risks, acceptability determination, and risk mitigation implementation.
Presentation Reinoud Bouwer
Presentation held during the workshop 'Biosecurity at the Science-Policy Nexus: Developing a Vision for the Future'
BIOSAFETY MANAGEMENT.ppt
This document discusses biosafety and biocontainment levels. It describes the risks associated with biological research, including hazards from pathogens and laboratory procedures. Pathogens are classified into four risk groups based on infectivity and severity of disease. Containment levels including biological and physical containment help reduce exposure risks. Primary containment involves laboratory practices and equipment while secondary containment involves facility design. Facilities are designated as biosafety level I, II or III depending on the risk group of pathogens handled.
Biosafety
The document discusses biosafety principles and practices for protecting laboratory personnel and the environment from exposure to potentially infectious biological materials and agents, including determining the risks posed by different agents, assessing those risks, and establishing biosafety levels and containment procedures appropriate to the level of risk.
Introduction to biosafety
The document provides an introduction to biosafety, explaining that it aims to reduce risk of exposure to infectious materials through proper safety precautions and procedures. It discusses the need for biosafety in laboratories processing infectious agents and around recombinant DNA to protect workers and the environment. The document also outlines different biosafety levels and associated practices, containment facilities, risk groups of pathogens, and considerations for risk assessments.
patient safety.pptx
This document discusses various hazards faced by healthcare workers and methods to control risks. It addresses bloodborne pathogens, chemical exposures, musculoskeletal disorders, and infectious diseases. For each hazard, it lists elimination, substitution, engineering controls, administrative controls, and personal protective equipment as approaches to risk control. Examples are provided such as proper sharps disposal, infection control training, patient lifting devices, negative pressure isolation rooms, and PPE like gloves and gowns. The overall purpose is to outline major occupational health and safety issues in healthcare and approaches to mitigate risks.
Biosafety
According to the Centre Of Disease Control and Prevention (CDC), Biosafety is the application of safety precautions that reduce a laboratorian’s risk of exposure to a potentially infectious material and limit contamination of the work environment and ultimately the community.
Similar to L 6 mangment (20)
Amee write-up on - POTENTIAL HAZARDS ASSOCIATED WITH WORK PRACTICES
Amee write-up on - POTENTIAL HAZARDS ASSOCIATED WITH WORK PRACTICES
Amee write-up on - POTENTIAL HAZARDS ASSOCIATED WITH WORK PRACTICES
Amee write-up on - POTENTIAL HAZARDS ASSOCIATED WITH WORK PRACTICES
Recently uploaded
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfChulalongkorn Allergy and Clinical Immunology Research Group
Pollen and Fungal allergy
Presented by Chaloemchai Chumsaengchotsakul, MD.
June 14, 2024Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Cervical Disc Arthroplasty ORSI 2024.pptx
Indication and installation of a mobile cervical disc prosthesis. Benefits of the PRODISC C VIVO mobile disc prosthesis (Centinel Spine)
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
This document outlines policies and procedures for handling narcotic and controlled drugs in NABH accredited hospitals.
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
In this presentation , SBP ( spontaneous bacterial peritonitis ) , which is a common complication in patients with cirrhosis and ascites is described in detail.
The reference for this presentation is Sleisenger and Fordtran's Gastrointestinal and Liver Disease Textbook ( 11th edition ).
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
Helminthiasis or Worm infestation in Children for Nursing students
Brief description worm infestation/Helminthiasis for Basic B.Sc Nursing students
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Breast cancer: Post menopausal endocrine therapy
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
PGx Analysis in VarSeq: A User’s Perspective
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
cosmetics and cosmeceuticals
Muskan
mpharm
2nd semester
Guru Gobind Singh college of pharmacy, yamunanagar, haryana
Recently uploaded (20)
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
Helminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing students
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Pune Call Girls 7339748667 AVAILABLE HOT GIRLS AUNTY BOOK NOW
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
pharmacy exam preparation for undergradute students.pptx
pharmacy exam preparation for undergradute students.pptx
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
L 6 mangment
- 1. مع التعامل مخاطر تجنب كيفية والسموم لالمراض المسببة العوامل البايولوجية
- 2. "Biorisk management” is the effective management of risks posed by working with infectious agents and toxins in laboratories; it includes a range of practices and procedures to ensure the biosecurity, biosafety, and biocontainment of those infectious agents and toxins. What are the key components of biorisk management? On the safety and security side, the risks associated with biological materials in the laboratory can be comprehensively managed through the implementation of three key components: risk assessment, risk mitigation and performance systems (4).
- 3. The biorisk management approach reducing the risk of unintentional exposure to pathogens and toxins or their accidental release (biosafety), and reducing the risk of unauthorized access, loss, theft, misuse, acceptable levels (laboratory biosecurity)
- 16. Description Type Security Access restrictions for external intruders to hazardous materials (e.g. stocks of pathogenic organisms) Physical Security Individual reliability checks of employees with access to hazardous materials to reduce the insider-threat Personnel Security Access restrictions on security sensitive information (e.g. DNA sequence data of pathogens) Information Security Special security provisions during transfer of materials on road, plane or ship often integrated in transport safety protocols Transfer Security Keeping inventories and applying export controls allow the detection diversion of biosecurity sensitive materials Material controls
- 17. Thank you